F 
Fujian Aonong Biological Technology Group Incorporation 603363.SS · CNY
Consumer Staples · Shanghai · 🇨🇳 China
2.74
+1.86%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥8.47bn
FY2016FY2025
Net income
CN¥77.6m
FY2016FY2025
Free cash flow
−CN¥77.0m
FY2016FY2025
Shareholders' equity
CN¥3.13bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥8.47bn | CN¥8.76bn | CN¥19.46bn | CN¥21.61bn | CN¥18.04bn | CN¥11.52bn | CN¥5.79bn | CN¥5.76bn | CN¥4.90bn | CN¥4.98bn |
| Gross profit | CN¥532.8m | CN¥395.6m | −CN¥1.31bn | CN¥657.3m | −CN¥170.5m | CN¥1.99bn | CN¥736.6m | CN¥782.4m | CN¥924.5m | CN¥871.2m |
| Research and development | CN¥49.8m | CN¥54.5m | CN¥148.9m | CN¥161.7m | CN¥113.9m | CN¥65.4m | CN¥72.9m | CN¥109.7m | CN¥107.3m | CN¥111.3m |
| Operating income | — | −CN¥849.6m | −CN¥3.11bn | −CN¥1.31bn | −CN¥1.39bn | CN¥1.14bn | CN¥78.1m | CN¥21.6m | CN¥149.1m | CN¥138.8m |
| Net income | CN¥77.6m | CN¥579.3m | −CN¥3.65bn | −CN¥1.04bn | −CN¥1.52bn | CN¥573.0m | CN¥29.2m | CN¥30.1m | CN¥108.1m | CN¥91.4m |
| Diluted earnings per share | 0.09 | 0.61 | -4.21 | -1.21 | -2.29 | 0.87 | 0.05 | 0.05 | 0.22 | 0.17 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥8.74bn | CN¥9.51bn | CN¥13.63bn | CN¥18.66bn | CN¥17.10bn | CN¥12.02bn | CN¥4.92bn | CN¥3.31bn | CN¥2.54bn | CN¥1.71bn |
| Cash and short-term investments | — | CN¥1.39bn | CN¥212.3m | CN¥721.7m | CN¥544.0m | CN¥572.3m | CN¥255.0m | CN¥170.9m | CN¥228.9m | CN¥174.3m |
| Total liabilities | CN¥5.16bn | CN¥6.44bn | CN¥14.13bn | CN¥15.23bn | CN¥14.91bn | CN¥8.12bn | CN¥3.64bn | CN¥2.30bn | CN¥1.57bn | CN¥1.12bn |
| Debt | CN¥1.28bn | CN¥2.40bn | CN¥6.18bn | CN¥8.98bn | CN¥9.21bn | CN¥4.50bn | CN¥1.54bn | CN¥1.24bn | CN¥751.4m | CN¥385.1m |
| Shareholders' equity | CN¥3.13bn | CN¥2.57bn | −CN¥963.0m | CN¥2.50bn | CN¥1.30bn | CN¥2.74bn | CN¥828.0m | CN¥813.8m | CN¥808.5m | CN¥473.1m |
| Shares outstanding | 865m | 951m | 868m | 857m | 664m | 657m | 619m | 643m | 487m | 526m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥152.9m | −CN¥116.8m | CN¥984.0m | CN¥663.6m | CN¥524.3m | CN¥406.0m | CN¥394.2m | CN¥27.3m | CN¥26.8m | CN¥129.0m |
| Capital spending | −CN¥229.9m | −CN¥262.7m | −CN¥511.8m | −CN¥1.50bn | −CN¥2.71bn | −CN¥3.29bn | −CN¥658.4m | −CN¥569.2m | −CN¥440.2m | −CN¥275.8m |
| Free cash flow | −CN¥77.0m | −CN¥379.5m | CN¥472.2m | −CN¥835.3m | −CN¥2.18bn | −CN¥2.89bn | −CN¥264.3m | −CN¥541.9m | −CN¥413.4m | −CN¥146.8m |
| Dividends paid | −CN¥84.5m | −CN¥76.4m | −CN¥294.9m | −CN¥373.7m | −CN¥102.8m | −CN¥51.8m | −CN¥10.9m | −CN¥73.7m | −CN¥26.1m | −CN¥17.8m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥2.32bn | CN¥2.21bn | CN¥2.14bn | CN¥2.37bn | CN¥2.17bn | CN¥1.78bn | CN¥1.84bn | CN¥2.27bn |
| Gross profit | −CN¥18.2m | CN¥93.8m | CN¥60.0m | CN¥137.2m | CN¥177.2m | CN¥151.6m | CN¥115.8m | CN¥178.4m |
| Operating income | −CN¥184.5m | −CN¥45.2m | −CN¥112.9m | −CN¥11.1m | CN¥18.1m | CN¥226.8m | CN¥1.26bn | −CN¥143.4m |
| Net income | −CN¥176.5m | −CN¥13.3m | −CN¥336.3m | CN¥53.1m | CN¥142.5m | CN¥218.3m | CN¥1.40bn | −CN¥279.0m |
| Diluted earnings per share | -0.20 | -0.02 | -0.39 | 0.06 | 0.16 | 0.25 | 1.47 | -0.29 |
| Cash from operations | — | — | — | CN¥29.0m | CN¥29.0m | −CN¥345.0m | — | −CN¥29.0m |
| Capital spending | −CN¥26.0m | −CN¥41.0m | −CN¥47.0m | −CN¥50.0m | −CN¥41.0m | −CN¥90.0m | −CN¥30.0m | −CN¥57.0m |
| Free cash flow | — | — | — | −CN¥21.0m | −CN¥12.0m | −CN¥435.0m | — | −CN¥86.0m |
| Total assets | CN¥8.81bn | CN¥8.85bn | CN¥8.74bn | CN¥9.15bn | CN¥9.17bn | CN¥9.19bn | CN¥9.51bn | CN¥11.81bn |
| Cash and short-term investments | — | — | — | CN¥698.1m | CN¥821.8m | CN¥844.4m | CN¥1.39bn | CN¥382.2m |
| Debt | CN¥1.21bn | CN¥1.26bn | CN¥1.28bn | CN¥862.4m | CN¥2.01bn | CN¥2.07bn | CN¥2.23bn | CN¥3.71bn |
| Shareholders' equity | CN¥2.96bn | CN¥3.10bn | CN¥3.13bn | CN¥3.34bn | CN¥3.18bn | CN¥2.93bn | CN¥2.57bn | −CN¥1.82bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -26.8% | -6.0% | 7.8% |
| Net income | — | -33.0% | 8.7% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 5.4% | 0.5% | 2.4% | 5.4% |
| Net margin | 3.8% | -6.9% | -5.7% | -4.1% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 51.4 | 5.8 | -1.4 | -10.6 | -5.5 | 14.2 | 258.9 | 137.9 | 63.6 |
| Price to sales | 0.5 | 0.4 | 0.3 | 0.5 | 0.5 | 0.7 | 1.3 | 0.7 | 1.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 8 Jun 2021.
| FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|
| Paid in the year | 0.15 | 0.077 | 0.019 | 0.027 |
- 13-for-10 split · 21 Oct 2020
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.